Skip to content

Clinical Trial of Leilong Pill in Recuperation of Yang-deficient Constitution with Chronic Nephritis

Clinical Trial of Leilong Pill in Recuperation of Yang-deficient Constitution with Chronic Nephritis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032903
Enrollment
Unknown
Registered
2020-05-15
Start date
2016-09-01
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

yang-deficient constitution

Interventions

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Those who meet the criteria for yang-deficient constitution (yang-deficient constitution conversion score is greater than or equal to 40 points); 2. Those who meet the criteria for kidney-yang-deficient syndromes; 3. Aged 18 to 65 years; 4. Those who voluntarily accept clinical trials and sign informed consent; 5. Those who meet the western medical diagnostic criteria for chronic nephritis.

Exclusion criteria

Exclusion criteria: 1. Those who have severe primary diseases such as heart, brain and hematopoietic system, severe liver and kidney damage, and pulmonary infection; 2. Those who are allergic to test drugs or its components; 3. Women who are in pregnancy or lactation; 4. Women who have mental illness; 5. Those who the doctor considers inappropriate for clinical trials; 6. Those who participated in other clinical trials within one month; 7. Those who withdraw before completing the entire course; 8. Those who take pinellia and its same species, fritillaria, ampelopsis japonica, polygonatum sibiricum; 9. Those who have the syndromes of yin deficiency with yang hyperactivity and exopath.

Design outcomes

Primary

MeasureTime frame
score reduction of scores of clinical symptom;

Secondary

MeasureTime frame
score reduction of scores of kidney-yang-deficient syndromes;urine protein;urinary occult blood;specific biomarkers;

Countries

China

Contacts

Public ContactBai Minghua

Beijing University of Chinese Medicine

751730367@qq.com+86 15101161095

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026